{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:46:28Z","timestamp":1785422788046,"version":"3.56.0"},"reference-count":84,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"unspecified","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Acta Neuropsychiatr."],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0924270826100702_as1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis aimed to quantify the magnitude of placebo and nocebo effects in pharmacological trials for OCRDs and identify clinical and methodological moderators influencing these effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924270826100702_as2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted across multiple databases and clinical trial registries up to May 2025. Randomised, placebo-controlled trials involving pharmacological interventions for OCRDs were included. The primary outcomes were placebo effect size and placebo response rate; secondary outcomes included nocebo response rate and side effect profile. Data were extracted independently and meta-analysed using random effects models. Meta-regression was performed to assess moderators of placebo response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924270826100702_as3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fifteen eligible trials (\n                      <jats:italic>N<\/jats:italic>\n                      = 640; placebo\n                      <jats:italic>N<\/jats:italic>\n                      = 341) were included. The pooled placebo effect size was moderate (SMC = \u22120.63; 95% CI \u22120.77 to \u22120.48), with low heterogeneity (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 4.73%). The placebo response rate was 21%, and the nocebo response rate was 18%. Despite testing a broad range of potential moderators, including clinical characteristics, methodological design, and medication class, no significant predictors of placebo effect size were identified. Side effects were reported in nearly one-third of placebo recipients, underscoring the relevance of nocebo effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0924270826100702_as4\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Placebo and nocebo responses are noteworthy in trials for OCRDs and may influence perceived treatment efficacy. Variability in placebo responses is not well explained by currently measurable moderators. Further research is needed to explore neurobiological, psychological, and methodological contributors to expectancy effects in OCRD pharmacotherapy trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/neu.2026.10070","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:01:59Z","timestamp":1774490519000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Placebo and nocebo effects of pharmacotherapy for obsessive\u2013compulsive related disorders: a systematic review and meta-analysis"],"prefix":"10.1017","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9877-9355","authenticated-orcid":false,"given":"Jacob","family":"Hoffman","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Neuroscience Institute, Faculty of Health Sciences, University of Cape Town"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-0459","authenticated-orcid":false,"given":"Taryn","family":"Williams","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Neuroscience Institute, Faculty of Health Sciences, University of Cape Town"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J.","family":"Stein","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Neuroscience Institute, Faculty of Health Sciences, University of Cape Town"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"S0924270826100702_ref32","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000185"},{"key":"S0924270826100702_ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"S0924270826100702_ref20","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Deeks","year":"2024"},{"key":"S0924270826100702_ref39","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"S0924270826100702_ref24","doi-asserted-by":"publisher","DOI":"10.1111\/ap.12392"},{"key":"S0924270826100702_ref33","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220737"},{"key":"S0924270826100702_ref53","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666181026163922"},{"key":"S0924270826100702_ref69","doi-asserted-by":"publisher","DOI":"10.1080\/17437199.2022.2125894"},{"key":"S0924270826100702_ref83","volume-title":"ICD-11: International Classification Of Diseases, 11th Revision","year":"2019"},{"key":"S0924270826100702_ref18","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbac061"},{"key":"S0924270826100702_ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2005.03.004"},{"key":"S0924270826100702_ref56","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.140343"},{"key":"S0924270826100702_ref27","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700001732"},{"key":"S0924270826100702_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2022.06.003"},{"key":"S0924270826100702_ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01397-3"},{"key":"S0924270826100702_ref9","first-page":"231","article-title":"N-Acetylcysteine in the treatment of pediatric trichotillomania: A randomized, double-blind, placebo-controlled add-on trial","volume":"52","author":"Bloch","year":"2013","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"S0924270826100702_ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711001738"},{"key":"S0924270826100702_ref37","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000382"},{"key":"S0924270826100702_ref28","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20111601"},{"key":"S0924270826100702_ref44","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02638-x"},{"key":"S0924270826100702_ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01789-0"},{"key":"S0924270826100702_ref78","volume-title":"Linear Mixed Models for Longitudinal Data","author":"Verbeke","year":"2009"},{"key":"S0924270826100702_ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2018.05.009"},{"key":"S0924270826100702_ref58","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411"},{"key":"S0924270826100702_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2018.07.033"},{"key":"S0924270826100702_ref81","first-page":"e7","volume-title":"Acta Neuropsychiatrica","volume":"38","author":"Wegener","year":"2026"},{"key":"S0924270826100702_ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2013.10.019"},{"key":"S0924270826100702_ref73","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"S0924270826100702_ref79","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i03"},{"key":"S0924270826100702_ref54","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000156"},{"key":"S0924270826100702_ref1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674211068793"},{"key":"S0924270826100702_ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.12.008"},{"key":"S0924270826100702_ref71","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.3204"},{"key":"S0924270826100702_ref67","first-page":"100","article-title":"Placebo and nocebo effect: A mini-review","volume":"26","author":"Po\u017egain","year":"2014","journal-title":"Psychiatria Danubina"},{"key":"S0924270826100702_ref72","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13000"},{"key":"S0924270826100702_ref61","first-page":"CD003012","article-title":"Active placebos versus antidepressants for depression","volume":"2004","author":"Moncrieff","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"S0924270826100702_ref62","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2022-300630"},{"key":"S0924270826100702_ref41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"S0924270826100702_ref36","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001005"},{"key":"S0924270826100702_ref7","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000078"},{"key":"S0924270826100702_ref63","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0111"},{"key":"S0924270826100702_ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002632"},{"key":"S0924270826100702_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.05.022"},{"key":"S0924270826100702_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.01.031"},{"key":"S0924270826100702_ref26","first-page":"1","article-title":"Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy","volume":"21","author":"Furukawa","year":"2018","journal-title":"Evidence-Based Mental Health"},{"key":"S0924270826100702_ref3","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-01-00484.1999"},{"key":"S0924270826100702_ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.0060"},{"key":"S0924270826100702_ref68","volume-title":"R: A language and environment for statistical computing","year":"2024"},{"key":"S0924270826100702_ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00407"},{"key":"S0924270826100702_ref35","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000037"},{"key":"S0924270826100702_ref66","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.4.381"},{"key":"S0924270826100702_ref5","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"key":"S0924270826100702_ref45","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyac009"},{"key":"S0924270826100702_ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s004060050044"},{"key":"S0924270826100702_ref80","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.11"},{"key":"S0924270826100702_ref82","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00801"},{"key":"S0924270826100702_ref38","unstructured":"Guy, W (1976) ECDEU assessment manual for psychopharmacology, Rev. 1976. ed. U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs: Rockville, Md.."},{"key":"S0924270826100702_ref49","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20245"},{"key":"S0924270826100702_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00486-3"},{"key":"S0924270826100702_ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02839-y"},{"key":"S0924270826100702_ref17","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0b013e3282b972fb"},{"key":"S0924270826100702_ref6","first-page":"367","article-title":"Efficacy of citalopram in treatment of pathological skin picking, a randomized double blind placebo controlled trial","volume":"46","author":"Arbabi","year":"2008","journal-title":"Acta Medica Iranica"},{"key":"S0924270826100702_ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01705-6"},{"key":"S0924270826100702_ref84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04424.x"},{"key":"S0924270826100702_ref60","doi-asserted-by":"publisher","DOI":"10.1177\/07067437221115029"},{"key":"S0924270826100702_ref21","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0711"},{"key":"S0924270826100702_ref12","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1176\/ajp.148.11.1566","article-title":"A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania","volume":"148","author":"Christenson","year":"1991","journal-title":"The American Journal of Psychiatry"},{"key":"S0924270826100702_ref74","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1176\/ajp.152.8.1192","article-title":"A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania","volume":"152","author":"Streichenwein","year":"1995","journal-title":"The American Journal of Psychiatry"},{"key":"S0924270826100702_ref16","doi-asserted-by":"publisher","DOI":"10.4324\/9780203774441"},{"key":"S0924270826100702_ref77","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05114gre"},{"key":"S0924270826100702_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30307-8"},{"key":"S0924270826100702_ref15","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587"},{"key":"S0924270826100702_ref34","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.60"},{"key":"S0924270826100702_ref51","first-page":"141","article-title":"The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. development and factor analyses","volume":"64","author":"Keuthen","year":"1995","journal-title":"Psychotherapy and Psychosomatics"},{"key":"S0924270826100702_ref40","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions, version 6.4","author":"Higgins","year":"2024"},{"key":"S0924270826100702_ref13","doi-asserted-by":"publisher","DOI":"10.2307\/3001666"},{"key":"S0924270826100702_ref46","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720003633"},{"key":"S0924270826100702_ref64","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4"},{"key":"S0924270826100702_ref30","doi-asserted-by":"publisher","DOI":"10.1017\/S109285292100095X"},{"key":"S0924270826100702_ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000490354"},{"key":"S0924270826100702_ref75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307083290220"},{"key":"S0924270826100702_ref57","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.88"},{"key":"S0924270826100702_ref19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1060937"},{"key":"S0924270826100702_ref76","volume-title":"EndNote","year":"2013"}],"container-title":["Acta Neuropsychiatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924270826100702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:59:49Z","timestamp":1784271589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924270826100702\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":84,"alternative-id":["S0924270826100702"],"URL":"https:\/\/doi.org\/10.1017\/neu.2026.10070","relation":{},"ISSN":["0924-2708","1601-5215"],"issn-type":[{"value":"0924-2708","type":"print"},{"value":"1601-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e29"}}